Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Head-to-head for women
Embody vs Lttl
Embody and Lttl both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Embody
Ranked #47 for women · Grade B−
Luna Fit
Best for: Women who want the lowest possible entry cost without signing a prepay commitment, and who would rather chew a medicated gum than inject.
Visit EmbodyLttl
Ranked #21 for women · Grade B−
Luna Fit
Best for: Readers treating insulin resistance who want the month-to-month rate rather than a prepay rung, and who will open the plan selector: the real ladder is public, complete and honest, and it is one click from a headline figure that is not.
Visit LttlThe verdict for women
Embody and Lttl tie on the Luna Fit Score at 81/100 apiece, so neither runs away with it. The right pick comes down to the factors that matter most to you — compare them below, or read the Embody scorecard and our Lttl write-up for women in full. If the answer is still neither, the Embody alternatives, scored on the same six factors widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Embody | Lttl |
|---|---|---|
| Luna Fit Score | 81/100 · B− | 81/100 · B− |
| Overall rank | #47 | #21 |
| Semaglutide | $79/mo, no commitment (starting dose, promotional rate; $299 list) | $199/mo month-to-month (from $129/mo on a 12-month plan billed $1,548 up front) — the product card advertises the $129 rung |
| Tirzepatide | $129/mo, no commitment (starting dose, promotional rate; $349 list) | $279/mo month-to-month (from $199/mo on a 12-month plan billed $2,388 up front) — the product card advertises $129, which no tirzepatide tier costs |
| Coverage | 49 states (not Louisiana) | All 50 states plus Washington D.C., with a stated caveat that some services may not be |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Luna Fit
Embody
Ranked #47 · Grade B−
What we like
- $79/mo semaglutide and $129/mo tirzepatide with no commitment — the lowest month-to-month figures in this ranking
- Names all four partner pharmacies (RedRock, Health Warehouse, Precision Compounding and Triad Rx) rather than referring vaguely to 'a licensed pharmacy'
- LegitScript certified
The caveats
- $79 is a starting-dose promotional rate against a $299 list price its own store still records, so it is the figure in this ranking most likely to move — the $69 seen elsewhere is the 12-month prepay rate, not a second monthly offer
- Not available in Louisiana, and the main site does not state coverage at all
- Copy says 'flat at every dose' in one place and 'starting at $79' in another, with no published dose table to settle it
Luna Fit
Lttl
Ranked #21 · Grade B−
What we like
- Publishes its entire price ladder — every product, every term, every rung — in the public page source, each one labeled with what it bills (“$199/mo every month” beside “$1,548 annually”), with no intake quiz standing between you and the number
- A genuine month-to-month rung exists and is purchasable for every product, with no contracts and no minimum term, so the prepay ladder is an optional discount rather than the only way in
- Both molecules across three routes — injection, orally disintegrating tablet, and lower-dose microdose lines sold as their own products with their own published ladders rather than quoted at the full-dose price
The caveats
- All fourteen product cards hardcode “from $129/mo”. For semaglutide that is the twelve-month rung billed $1,548 up front; for tirzepatide, the semaglutide ODT and the microdose ODT it is a price purchasable at no tier at all
- The month-to-month rates are roughly 40% above the advertised figure — $199 for semaglutide and $279 for tirzepatide against the $129 on every card
- Names no medical director and no prescribing clinician, offers and requires no labs or bloodwork, and carries no third-party certification such as LegitScript
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Embody nor Lttl is only worth comparing with the other. Embody is also written up against CoreAge Rx, 12 points apart on the Luna Fit Score — see the Embody–CoreAge Rx head-to-head. Lttl is also written up against CoreAge Rx, 12 points apart — see Lttl against CoreAge Rx, factor by factor.
- Embody vs CoreAge Rx
- Embody vs Enhance MD
- Embody vs Eden
- Lttl vs yourEra
- Lttl vs Sesame Care
- Lttl vs HealthRX
Or browse the full comparison hub.